Gilead Sciences to Release Third Quarter 2012 Financial Results on Tuesday,
October 23, 2012
Conference Call and Webcast to Follow
FOSTER CITY, Calif. -- October 16, 2012
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter
2012 financial results will be released on Tuesday, October 23, at 4:05 p.m.
Eastern Time. At 4:15 p.m. Eastern Time, Gilead’s management will host a
conference call to discuss the company’s financial results for the third
quarter 2012 and provide a general business update. The conference call will
be accessible via the internet from the company’s website.
To access the webcast link, log on to www.gilead.com. Please connect to the
company’s website at least 15 minutes prior to the conference call to ensure
adequate time for any software download that may be required to listen to the
webcast. Alternatively, please call 1-800-659-1966 (U.S.) or 1-617-614-2711
(international) and dial the participant passcode 31853534 to access the call.
Telephone replay will be available approximately two hours after the call
through 11:59 p.m. Eastern Time, October 26, 2012. To access the replay,
please call 1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial
the participant passcode 84574172. The webcast will be archived on
www.gilead.com for one year.
Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please visit www.gilead.com or call
the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor Relations)
Press spacebar to pause and continue. Press esc to stop.